Strategies for cancer control during COVID-19 pandemic |
Adaptation of service delivery models to maintain cancer services |
Use of telehealth, technology and tele-mentoring |
Health workers developed a joint understanding and appreciation of effective telehealth communication in cancer care
Enhancement of digital platforms in cancer care, telehealth and drone drug delivery
|
Developing, modifying and sharing cancer treatment protocols |
|
Reconfiguring chemotherapy infusion centres, screening space and patient waiting areas. |
|
Decentralisation of cancer treatment to local and lower-level facilities |
|
COVID-19 related challenges and unresolved dilemmas |
Fear of exposure to COVID-19 infection at the health facility, by both patients and health workers |
Lack of PPE |
|
Crowded and congested hospital space and chemotherapy infusion space |
Lack of room for social distancing/isolation due to open patient wards |
Lack of readily accessible washing facilities |
Lack of psychosocial support services to allay fear and anxiety |
Overall disruption of cancer services spanning the whole cancer control continuum |
Travel restrictions |
|
Diversion of already scarce resources (staff and money) to the COVID-19 response |
Limited access to health facilities |
Compromised supply chain for cancer drugs, equipment and clinic supplies |
Lack of electronic data collection systems |
Challenges of telehealth and technological limitations |
Patient discomfort with telehealth and technology |
|
Slow bandwidth and Internet connectivity |
High Internet costs and mobile airtime |
Inadequate skills/capacity in use of telehealth and telecommunication for physical assessments by health workers |
Recommendations for cancer control during and after the COVID-19 pandemic |
Health system strengthening |
Integrating cancer control services in the health service structures |
|
Continuing and increasing use of digital technology for cancer control |
Creating and sharing contextualised guidelines for cancer control in Africa |
Leveraging the infrastructure and momentum developed in response to COVID-19 pandemic to further strengthen cancer response |
Developing well-conceived and comprehensive NCCPS |